Cachet Pharmaceutical Co., Ltd. (SHE:002462)
China flag China · Delayed Price · Currency is CNY
10.13
-0.17 (-1.65%)
Nov 18, 2026, 3:05 PM CST

Cachet Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
2,2732,5592,2232,8852,1842,338
Trading Asset Securities
-5.140.170.140.160.23
Cash & Short-Term Investments
2,2732,5642,2232,8862,1842,338
Cash Growth
7.79%15.32%-22.95%32.14%-6.61%15.85%
Accounts Receivable
5,2536,0547,1719,2058,8858,039
Other Receivables
55.8180.2682.7331.79390.51113.61
Receivables
5,3096,1347,2549,5379,2768,153
Inventory
1,9672,4652,7392,5622,6922,185
Other Current Assets
430.92671.72788.03646.38843.66609.02
Total Current Assets
9,97911,83513,00515,63114,99613,285
Property, Plant & Equipment
359.68404.33465.38679.74735.93850.26
Long-Term Investments
1.891.891.871.742.442.53
Goodwill
346.51346.51395.45475.86515.92562.38
Other Intangible Assets
24.624.9624.4535.5835.7936.58
Long-Term Accounts Receivable
--3.5627.3233.56-
Long-Term Deferred Tax Assets
70.2872.5173.0392.9768.1552.57
Long-Term Deferred Charges
52.0657.863.45171144.35122.8
Other Long-Term Assets
5.425.615.856.124.8925.14
Total Assets
10,83912,74814,03817,12116,55714,938

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
3,4644,2164,4745,8585,3204,442
Accrued Expenses
67.43147.78160.5971.4253.8162.23
Short-Term Debt
869.251,7892,6773,8824,1124,002
Current Portion of Leases
24.4836.758.1754.8949.758.16
Current Income Taxes Payable
44.8558.5442.9382.271.2960.31
Current Unearned Revenue
123.59147.03186.31433.63291.82309.06
Other Current Liabilities
325371.43314.32467.01517.2687.43
Total Current Liabilities
4,9186,7677,91410,84910,4159,022
Long-Term Debt
10-----
Long-Term Leases
91.79104.37130.09175.95208.76229.24
Long-Term Deferred Tax Liabilities
0.591.390.764.311.2429.95
Total Liabilities
5,0206,8738,04511,02910,6359,281

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
291.71291.71291.71291.71291.71291.71
Additional Paid-In Capital
1,2921,2921,2921,2911,2911,288
Retained Earnings
2,7792,7682,7062,6582,4952,306
Total Common Equity
4,3634,3524,2904,2414,0783,887
Minority Interest
1,4561,5241,7031,8511,8441,770
Shareholders' Equity
5,8195,8765,9936,0925,9225,657
Total Liabilities & Equity
10,83912,74814,03817,12116,55714,938

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
995.521,9302,8664,1134,3704,290
Net Cash (Debt)
1,277633.82-642.28-1,227-2,186-1,951
Net Cash Growth
3203.20%-----
Net Cash Per Share
4.302.16-2.19-4.22-7.51-6.67
Filing Date Shares Outstanding
291.71291.71291.71291.71291.71291.71
Total Common Shares Outstanding
291.71291.71291.71291.71291.71291.71
Working Capital
5,0615,0685,0914,7814,5814,263
Book Value Per Share
14.9614.9214.7114.5413.9813.32
Tangible Book Value
3,9923,9803,8703,7293,5263,288
Tangible Book Value Per Share
13.6913.6413.2712.7812.0911.27
Buildings
-273.07273.07273.07273.07273.07
Machinery
-247.36247.57882.53797.4723.89
Construction In Progress
-3.181.09-1.565.08